King Wealth Bristol Myers Squibb CO Transaction History

King Wealth

$642 Million
Q3 2024

A detailed history of King Wealth transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, King Wealth holds 7,112 shares of BMY stock, worth $414,131. This represents 0.06% of its overall portfolio holdings.

Number of Shares

7,112

Previous 7,206 1.3%

Holding current value

$414,131

Previous $299,000 23.08%

% of portfolio

0.06%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$39.66 - $51.75 $3,728 - $4,864	-94 Reduced 1.3%	7,112 $368,000
Q2 2024 Aug 08, 2024	BUY	$40.25 - $52.99 $12,558 - $16,532	312 Added 4.53%	7,206 $299,000
Q1 2024 May 09, 2024	BUY	$47.98 - $54.4 $13,290 - $15,068	277 Added 4.19%	6,894 $374,000
Q4 2023 Feb 08, 2024	BUY	$48.48 - $57.85 $5,623 - $6,710	116 Added 1.78%	6,617 $339,000
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $3,415 - $3,819	59 Added 0.92%	6,501 $377,000
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $7,199 - $7,993	113 Added 1.79%	6,442 $412,000
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $3,416 - $3,875	52 Added 0.83%	6,329 $439,000
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $136 - $162	2 Added 0.03%	6,277 $452,000
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $0 - $153	2 Added 0.03%	6,275 $446,000
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $6,390 - $7,038	-88 Reduced 1.38%	6,273 $483,000
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $5,287 - $6,339	-86 Reduced 1.33%	6,361 $465,000
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $214 - $250	4 Added 0.06%	6,447 $402,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $11,597 - $13,584	-196 Reduced 2.95%	6,443 $381,000
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $309 - $337	5 Added 0.08%	6,639 $444,000
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $296 - $333	5 Added 0.08%	6,634 $419,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $288 - $327	5 Added 0.08%	6,629 $411,000
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $286,862 - $317,881	-4,995 Reduced 42.99%	6,624 $399,000
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $329,139 - $384,796	6,004 Added 106.93%	11,619 $683,000
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $46,214 - $67,160	-996 Reduced 15.07%	5,615 $313,000
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $22,292 - $29,078	453 Added 7.36%	6,611 $424,000
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $192,336 - $228,042	-4,497 Reduced 42.21%	6,158 $313,000
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $67,063 - $74,158	1,503 Added 16.42%	10,655 $483,000
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $36,863 - $43,954	-817 Reduced 8.2%	9,152 $436,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $197,526 - $256,144	4,051 Added 68.45%	9,969 $518,000
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $9,492 - $10,707	172 Added 2.99%	5,918 $368,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $20,060 - $25,003	-397 Reduced 6.46%	5,746 $318,000
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $9,167 - $10,553	153 Added 2.55%	6,143 $389,000
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $119 - $130	2 Added 0.03%	5,990 $367,000
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $110 - $127	2 Added 0.03%	5,988 $382,000
Q2 2017 Aug 14, 2017	BUY	N/A	5,986	5,986 $334,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

News

Stay updated on King Wealth with notifications on news.

Account